[Stem cell research and science and technology policy in Japan].

研究成果: ジャーナルへの寄稿総説査読

抄録

In this paper I review the present condition of the regeneration medicine research using pluripotency and a somatic stem cell, and I describe the subject of the science and technology policy in Japan towards realization of regeneration medicine. The Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) supported research promotion by the prompt action in 2007 when establishment of the iPS cell was reported by Shinya Yamanaka. Although the hospitable support of the Japanese government to an iPS cell is continued still now, there are some problems in respect of the support to other stem cell researches, and industrialization of regeneration medicine. In order to win a place in highly competitive area of investigation, MEXT needs to change policy so that funds may be widely supplied also to stem cell researches other than iPS cell research.

本文言語英語
ページ(範囲)2251-2256
ページ数6
ジャーナルNihon rinsho. Japanese journal of clinical medicine
69
12
出版ステータス出版済み - 12-2011
外部発表はい

All Science Journal Classification (ASJC) codes

  • 医学一般

フィンガープリント

「[Stem cell research and science and technology policy in Japan].」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル